Back to calendar
Gossamer Bio, Inc. (GOSS) Earnings
GOSS reports earnings on Thursday, August 13, 2026
earnings report
August 13, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.12
Actual EPS: $-0.20
EPS surprise: -20.85%
Company overview
Market Cap$83.4M
PriceUSD 0.17
EPS (TTM)-0.79
52-week high3.87
52-week low0.11
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees162